A large body of evidence suggests that oxidized LDL (oxLDL) has a role in atherogenesis. One effect is the impact on macrophage function. We have studied the effects of oxLDL and oxysterols on the binding of the transcription factors nuclear factor (NF)-kappaB and AP-1 to DNA. These transcription factors are involved in the regulation of several genes and expressed during activation of macrophages, for example by endotoxin (LPS). OxLDL did not induce binding of NF-kappaB. However, the LPS-induced response to NF-kappaB was substantially reduced after preincubation with oxLDL. Medium and highly oxidized LDL also decreased the constitutive DNA-binding of AP-1. Similar effects on AP-1-binding were seen with the oxysterols, 7beta-hydroxycholesterol, 24-hydroxy-, 25-hydroxy-, and 27-hydroxycholesterol. Our data therefore suggest an effect of oxLDL on the DNA-binding of AP-1, which might be mediated by the oxysterol content of oxLDL. A decreased LPS-induced TNF-alpha and IL-1beta mRNA and protein expression were found in macrophages incubated with oxLDL before LPS-exposure. These observations suggest that macrophages that internalize extensively oxidized LDL are suppressed in their response to inflammatory stimulation.
Introduction
Much attention has been given to the role of oxidized LDL (oxLDL) 1 and oxidized lipids in atherosclerosis. Oxidized lip-ids have been shown in atherosclerotic lesions, and immunohistochemistry suggests that oxLDL is deposited in the lesions. How oxidized lipid products and oxLDL affect the initiation and progression of atherosclerotic lesion still is largely unknown. OxLDL has been shown to have a pleiotropic effect on cellular functions. In a series of studies, the biological effects of minimally modified LDL (MM-LDL) have been studied. These studies show that MM-LDL induces IL-1 ␤ in monocytes. In endothelial cells MM-LDL may induce the expression of colony stimulating factor, monocyte chemoattractant protein 1, and tissue factor (1) (2) (3) (4) . In endothelial cells it has also been shown that MM-LDL induces the transcription factor nuclear factor (NF)-B to bind to its binding site on DNA (5) .
More extensively oxidized LDL seems to have different effects than MM-LDL on cellular functions. It stimulates the production of monocyte chemotactic factor in endothelial cells and potentiates monocyte-endothelial cell adhesion (6) . Other suggested effects are proliferation of smooth muscle cells, differentiation of macrophages, induction of endothelial cell expression of granulocyte and macrophage colony-stimlulating factors, and recruitment and retention of macrophages during atherogenesis (3, 7) . At higher concentration oxLDL is cytotoxic (6, (8) (9) (10) .
In macrophages oxLDL inhibits the lipopolysaccharideinduced IL-1 ␤ and TNF-␣ gene expression (11, 12) . The mechanism for this inhibition is unknown. The regulation of the TNF-␣ gene is regulated by the transcription factor NF-B, which binds to regulatory elements in the promotor of the TNF-␣ gene (13) . These regulatory elements are conserved in mouse, rabbit, and human and might therefore play an important role in the regulation of the TNF-␣ gene expression in several species (14) . Lipopolysaccharide (LPS) induces binding of NF-B to DNA and expression of the TNF-␣ gene is therefore used to induce an inflammatory response in macrophages (13, 15) . The IL-1 ␤ promotor has one binding site for NF-B, but also two AP-1-binding sites and one serum responsive element (SRE) (16) .
In this report we have studied the effects of oxLDL on the LPS-induced DNA-binding of the transcription factors NF-B, AP-1 and the transcription factor complex of serum responsive factor (SRF), and serum responsive factor accessory protein-1a (SAP-1) to DNA. We have also studied the LPS-induced mRNA and protein expression of the TNF-␣ and IL-1 ␤ genes in macrophages exposed to oxLDL. NF-B is located in the cytosol in a complex with its inhibitor I-B (17, 18) . This complex dissociates when I-B is phosphorylated by extracellular signals and NF-B is then translocated into the nucleus, where it binds to DNA (19) (20) (21) (22) . We have also studied the DNA-binding of the transcription factor AP-1, since it regulates transcription of the IL-1 ␤ gene and several other genes that are also induced by LPS (23). AP-1 appears both as a heterodimer of the transcription factors c-jun and c-fos and a homodimer of c-jun via hydrophobic interactions (23). The binding of AP-1 to DNA as well as the transcriptional activity of the AP-1 complex are regulated both by phosphorylation and dephosphorylation (23, 24) . The IL-1 ␤ promotor contains both two AP-1binding sites and one serum responsive element (16) . The c-fos promotor contains an AP-1-binding site located adjacent to SRE (25) . The transcription factors SRF and SAP-1 bind to SRE and are both necessary for a proper induction of the transcription of the c-fos gene (26, 27) . The SRF ϩ SAP-1 complex becomes transcriptionally active after SAP-1 has been phosphorylated (28) .
An oligonucleotide, from the c-fos promotor that contains the AP-1-binding site adjacent to SRE was used for electrophoretical mobility shift assay (EMSA) to investigate the binding of both AP-1 and SRF ϩ SAP-1 to DNA (25) . The transcription factor c-fos is a protein component in the AP-1 complex and is therefore able to bind to the c-fos promotor. The SRF ϩ SAP-1 complex upregulates the transcription of the c-fos gene (26) (27) (28) . A decreased binding of the SRF ϩ SAP-1 complex to the c-fos promotor, would probably lead to a decreased transcription of the c-fos gene, followed by a subsequent decrease of the DNA-binding of AP-1 to the c-fos promotor. The effect of a change in binding of NF-B to DNA, caused by oxLDL, was studied on the TNF-␣ and IL-1 ␤ mRNA expression. In addition, the TNF-␣ and IL-1 ␤ protein synthesis were also monitored.
Oxidized lipids, among these oxysterols, are formed during oxidation of LDL (29) . Oxysterols are biologically active substances, which can alter vascular permeability (30, 31) , inhibit the LPL mRNA expression in human foam cells (32) and the LDL receptor function in human fibroblasts (33). Furthermore, oxysterols have been identified in tissue from atherosclerotic human aortas (34) (35) (36) (37) (38) (39) . We have therefore studied the effects of oxysterols on the binding of NF-B and AP-1 to DNA to identify components in oxLDL that could mediate changes in the binding of transcription factors to DNA. Here we report that oxidized LDL decreased the LPS-induced DNA-binding of NF-B in human macrophages. This decreased binding of NF-B was followed by a low TNF-␣ and IL-1 ␤ mRNA and protein expression. In addition, we found that oxysterols decreased the binding of AP-1 to DNA.
Methods
Macrophage culture condition. Human monocyte-derived macrophages were isolated by Ficoll-Paque (Pharmacia Fine Chemicals, Uppsala, Sweden) in a discontinous gradient from buffy coats, which were obtained from the Blood Bank, Sahlgren's Hospital (Göteborg, Sweden) (40) . The mononuclear cell preparations were washed five times with PBS, pH 7.2, without calcium and magnesium, but containing 10 mM EDTA. The cell preparation was performed at room tem-perature. Mononuclear cells were resuspended and seeded at a density of 10 7 cells per each 100-mm plastic dish in a serum-free medium (Macrophage-SFM; GIBCO BRL, Grand Island, NY), supplemented with penicillin 100 U/ml and streptomycin 100 g/ml. Monocytes were allowed to adhere for 1 h. Nonadhered cells were eliminated with three washes with PBS. Adherent monocytes were cultured in Macrophage-SFM medium with antibiotics and supplemented with human granulocyte macrophage colony stimulating factor (GM-CSF), 70 U/ml (R&D Systems Europe Ltd., Abingdon, UK). The medium was discarded after 3 d and the cells were washed once with PBS. The macrophages were then allowed to grow for another 3 d in the same medium, but without GM-CSF.
Preparation of human LDL. Human LDL ( d 1.019-1.063 g/ml) was prepared by sequential ultracentrifugation (4 Њ C) of plasma from healthy, fasted male volunteers, in the presence of EDTA (0.2% wt/ vol) (41) . The LDL preparations were filtered through 0.22-m filters, stored at 4 Њ C, and used within 1 wk of preparation.
Oxidation of low density lipoprotein. After extensive dialysis against PBS for 24 h, oxidation of LDL was performed by incubating 0.1 mg LDL protein/ml in PBS containing 5 M CuSO 4 for 2.5, 4, and 13 h at 37 Њ C, as described by Steinbrecher et al. (42) . The oxidation was stopped by adding butylated hydroxytoluene(2,6-dit -butylp -creso-1) (Sigma Chemical Co., St. Louis, MO) to a final concentration of 0.1 mM. Oxidized LDL was separated from CuSO 4 and equilibrated into the cell culture medium over a PD-10 column (Pharmacia Fine Chemicals). The protein content of LDL was determined according to Bradford (43) . TBAR levels after oxidation typically were 17, 38, and 55 nmol MDA/mg protein after 2.5, 4, and 13 h oxidation, respectively. In agreement with these results an increasing shift in electrophoretical mobility was seen.
The different degrees of oxidation were also tested by analyzing the uptake of oxLDL into macrophages in culture. These experiments were performed as described by Goldstein and Brown (44) using human monocyte-derived macrophages under the conditions described in the present study. Iodinated ( 125 I; Amersham International, Amersham, UK) oxLDL was added to the cell culture medium at a protein concentration of 50 g/ml, sp act 50-100 cpm/ng. After 4 h incubation the degradation of LDL was estimated from the chloroform-extracted, acid soluble radioiodine in the medium (45) . Cellular uptake was determined as cell-associated radioactivity. In all experiments parallel wells without cells were incubated as controls for nonspecific adsorption or degradation. These experiments were performed in quadruplicates and repeated four times. The results obtained showed that the macrophage uptake of low oxLDL, oxidized for 2.5 h, was on an average 25.3 ng 125 I-LDL/mg cell protein, while the uptake of medium oxLDL, oxidized for 4 h, was on an average 51.3 ng 125 I-LDL/mg cell protein. When highly oxidized LDL was used, oxidized for 13 h, an uptake of an average of 120 ng 125 I-LDL/ mg cell protein was observed. The results showed a significant difference with respect to macrophage uptake between low, medium, and high oxLDL. The same figures for degradation were 11.8, 21.4, and 34.0 ng 125 I-LDL/mg cell protein, for oxLDL oxidized 2.5, 4, and 13 h respectively.
In conclusion, the degree of oxidation was studied with three different methods. Increased electrophoretical mobility was observed after LDL was submitted to oxidation. Also, the TBAR levels increased after oxidation. Finally, an increased macrophage uptake and degradation of oxidized LDL was found. Using the Cell proliferation kit II (XTT; Boehringer Mannheim, Mannheim, Germany) no differences in cell viability were found between untreated macrophages and cells treated with the different oxLDL preparations.
The presence of endotoxins in the lipoprotein preparations were analyzed by the Coatest endotoxin kit (Chromognix, Mölndal, Sweden) according to the manufacturer's instructions. Only preparations of oxLDL, which had Ͻ 8 pg LPS/ml were used for the experiments.
Experimental procedure. 6 d after plating of the monocytes, from one blood donor, the medium was replaced with the same medium, but now supplemented with either oxLDL, 50 g protein per ml, or oxysterols, 5 g/ml. 7-ketocholesterol, 7 ␤ -hydroxycholesterol, 25hydroxycholesterol purchased from Sigma Chemical Co., and 24hydrocholesterol and 27-hydroxycholesterol kindly provided by Dr. U. Diczfalusy, Huddinge University Hospital (Huddinge, Sweden) were used. The oxysterols dissolved in ethanol were added to the medium in the final concentration of 1 l per ml medium. To control cells only the ethanol vehicle was added. This medium was replaced after 24 h incubation, by a medium with or without LPS, 1 g/ml (Sigma Chemical Co.). 1 h after incubation with LPS, the preparations of nuclear protein extracts were started.
Preparation of nuclear protein extract. The macrophages were washed three times with cold PBS and collected by scraping the dish with a cell lifter, in 2 ml hypotonic buffer, pH 7.9, containing 10 mM Hepes, pH 7.9, 0.1 mM EDTA, 10 mM KCl, powdered nonfat milk 5 mg/ml, 0.75 mM spermidine, 0.15 mM spermine, 1 mM DTT (Boehringer Mannheim Biochemical), pepstatin 50 g/ml, leupeptin 50 g/ ml, chymostatin 50 g/ml, antipain 50 g/ml, benzamidine 78 g/ml, and 0.5 mM PMSF (Sigma Chemical Co.). The macrophages were homogenized by 8 strokes with a B pestle in a Dounce homogenizer. The nuclei were collected by centrifugation at 30,000 g at 4 Њ C for 10 min. The pellet containing the nuclei was resuspended in 250 l eluting buffer; 20 mM Hepes, pH 7.9, 25% glycerol, 0.42 M NaCl, 1 mM EDTA, 1 mM EGTA, 1 mM DTT, and supplemented with the proteinase inhibitors in the same concentrations as in the hypotonic buffer. After 45 min extraction at 4 Њ C, nuclei were sedimented at 30,000 g at 4 Њ C for 1 h, and the nuclear proteins were collected and stored in aliquotes at Ϫ 70 Њ C. Protein concentrations of the nuclear proteins obtained from the macrophages were measured according to Bradford (43) .
Recombinant human c-jun that forms homodimers of the AP-1 complex was purchased from Promega Corp., Madison, WI.
Constructions of oligonucleotides. Oligonucleotides were synthesized on an oligonucleotide synthesizer (Applied Biosystems Inc., Foster City, CA). Single-stranded oligonucleotides were, after purification, Figure 3 . Effects of oxLDL on the LPS-induced binding of NF-B. NE from human macrophages were analyzed with electrophoretic mobility shift assay. Binding of NF-B was analyzed by an oligonucleotide from the human TNF-␣ promotor Ϫ646 to Ϫ613. An equal protein amount of nuclear extract (NE) was added to each binding reaction. NE from untreated macrophages (C), macrophages treated with oxLDL, 50 g/ml, for 24 h (O), treated with LPS, 1 g/ml, for 1 h (L), and macrophages treated with oxLDL, 50 g/ml for 24 h before exposure of LPS, 1 g/ml, for 1 h (P). The results obtained after laser densitometry scans of the shifted bands corresponding to NF-B are shown. LPS-induced DNA-binding of NF-B was set to 100%. The results are represented as mean values from five experiments and SEM is indicated.
Nuclear protein extracts (NE) from human monocytederived macrophages, analyzed for binding to ␣ 32 P-labeled DNA oligonucleotides by electrophoretic mobility shift assay. An oligonucleotide from the human c-fos promotor Ϫ325 to Ϫ284 containing the SRE and AP-1-binding site was used to identify binding of SRF ϩ SAP-1 and AP-1. Binding of NF-B was analyzed by an oligonucleotide from the human TNF-␣ promotor, Ϫ646 to Ϫ613. An equal protein amount of NE was added to each binding reaction. NE from untreated macrophages (C), macrophages treated with oxLDL, 50 g/ml, for 24 h (O), treated with LPS, 1 g/ml, for 1 h (L), and macrophages treated with oxLDL, 50 g/ml for 24 h before exposure of LPS, 1 g/ml, for 1 h (P). The identified transcription factors SRF ϩ SAP-1, AP-1, and NF-B are indicated. Unbound oligonucleotide is at the bottom of the lanes.
annealed overnight. The annealed product was separated by a polyacrylamide gel electrophoresis and electroeluted from the gel at 50 V overnight. A double-stranded oligonucleotide identical to the sequence from Ϫ646 to Ϫ613 in the human TNF-␣ promotor, containing a B-site, was used to identify binding of NF-B (14) . As a specific competitor to this B-site a double-stranded oligonucleotide, containing a Bsite from Ϫ223 to Ϫ190 in the same TNF-␣ promotor was used (14) .
The c-fos gene promotor sequence from -325 to -284, illustrated in Fig. 1 , containing the serum responsive element (underlined) and the AP-1 binding site, indicated by bold letters, (TTACACAGGATG-TCCATATTAGGACATCTGCGTCAGCAGGTT) was constructed.
A double-stranded oligonucleotide containing the consensus sequence of the AP-1 motif, with the sequence TTCCGGCTGACT- Figure 5 . Effects of oxLDL on the constitutive binding of SRF ϩ SAP-1. NE from human macrophages were analyzed with electrophoretical mobility shift assay. DNA-binding of the SRF ϩ SAP-1 complex was analyzed by an oligonucleotide from the human c-fos promotor Ϫ325 to Ϫ284. An equal protein amount of NE was added to each binding reaction. NE from untreated macrophages (C), macrophages treated with oxLDL, 50 g/ml, for 24 h (O), treated with LPS, 1 g/ml, for 1 h (L), and macrophages treated with oxLDL, 50 g/ml for 24 h before exposure of LPS, 1 g/ml, for 1 h (P). The results obtained after laser densitometry scans of the shifted bands corresponding to SRF ϩ SAP-1 complex are shown. LPS-induced DNAbinding of the SRF ϩ SAP-1 complex was set to 100%. The results are represented as mean values from five experiments, and SEM is indicated. Figure 4 . Effects of oxLDL on the constitutive binding of AP-1. NE from human macrophages were analyzed with electrophoretical mobility shift assay. DNA-binding of AP-1 was analyzed by an oligonucleotide from the human c-fos promotor Ϫ325 to Ϫ284. An equal protein amount of nuclear extract (NE) was added to each binding reaction. NE from untreated macrophages (C), macrophages treated with oxLDL, 50 g/ml, for 24 h (O), treated with LPS, 1 g/ml, for 1 h (L), and macrophages treated with oxLDL, 50 g/ml for 24 h before exposure of LPS, 1 g/ml, for 1 h (P). The results obtained after laser densitometry scans of the shifted bands corresponding to AP-1 are shown. LPS-induced DNA-binding of AP-1 was set to 100%. The results are represented as mean values from five experiments and SEM is indicated. Figure 6 . The reversible effect of oxLDL on the DNA-binding of NF-B and AP-1. NE from human macrophages were analyzed with electrophoretic mobility shift assay. Binding to an ␣ 32 P-labeled oligonucleotide from the c-fos promotor containing a SRE and an AP-1binding site and the NF-B-binding site from the TNF-␣ promotor and a consensus sequence of the oct-1binding motif were investigated. An equal protein amount of NE was added to each binding reaction. A indicates NE from macrophages treated with LPS, 1 g/ml, for 1 h (L) and NE from cells incubated with highly oxidized LDL, 50 g/ml, for 24 h before LPS exposure, 1 g/ ml, for 1 h (P). B indicates macrophages that have been incubated for 3 d; macrophages treated with LPS, 1 g/ml, for 1 h (L); macrophages incubated with the same highly oxidized LDL, 50 g/ml, for 24 h as under A, followed by an incubation without oxLDL for another 2 d before exposure of LPS, 1 g/ml, for 1 h (P). The identified transcription factors NF-B, SRF ϩ SAP-1 and AP-1 are indicated. Unbound oligonucleotide is at the bottom of the lanes.
CAAGCG, was used to identify specific binding of AP-1 ( Fig. 1) (46, 47) . The binding motif is underlined. A double-stranded oligonucleotide, TGTCGAATGCAAATCACTAGAA, containing the consensus sequence of the octamer binding motif (underlined) was used to identify specific binding of the transcription factor oct-1. This transcription factor regulates transcription of a number of so-called housekeeping genes (48) .
Electrophoretic mobility shift assay. For gel mobility shift assays, double-stranded oligonucleotides radiolabeled with ␣ 32 P-labeled deoxynucleotide, using Klenow polymerase (Boehringer Mannheim Biochemical), were used. The protein-DNA binding reaction was carried out in a volume of 20 l containing 20 mM Tris-HCl, pH 7.9, 75 mM NaCl, 0.1 mM EGTA, 1 mM DTT, 5% glycerol and 5 g of poly(dI-dC)poly(dI-dC) (Pharmacia Biotech). Approximately 80,000 Cerenkov cpm, corresponding to 2 ng of the probe, was added to each reaction, which proceeded at room temperature for 20 min after the same amount of protein extracts had been added to every reaction. In some experiments, rabbit polyclonal IgG towards the p65 subunit of NF-B and towards SAP-1 and c-fos (Santa Cruz Biotechnology, Santa Cruz, CA) were added to the binding reactions. Competitions were performed by inclusion molar excess of unlabeled doublestranded oligonucleotides.
The reaction mixtures were then electrophoresed through a native 5% polyacrylamide gel containing 0.25 ϫ TBE (2.2 mM Tris borate, 2.2 mM boric acid, 0.5 mM EDTA) and 3% glycerol to separate DNA-protein complexes from unbound DNA-probe. Gels were vacuum dried and exposed to a photographic film at Ϫ80ЊC. The retarded bands, obtained after EMSA, corresponding to NF-B, AP-1 and SRF ϩ SAP-1 were quantitated by scanning the autoradiographs in an LKB Ultrascan laser densitometer. To compare these quantitative data between experiments from different donors, the binding obtained for the transcription factors NF-B, AP-1, and SRF ϩ SAP-1 to the DNA-oligonucleotides after macrophages were treated with LPS was set to 100% for each experiment.
Preparation and analysis of RNA. Total cellular RNA was isolated from differentiated macrophages by guanidinium-hydrochloride/isothiocyanate extraction and CsCl gradient ultracentrifugation (49) . A quantitative RT-PCR method described by Wang et al. (50) and modified by Mattsson et al. (51) was used to quantitate mRNA for TNF-␣ and IL-1␤. The reverse transcription reaction was performed with the Gene Amp RNA PCR kit (Perkin Elmer, Foster City, CA) using 1-100 ng of total RNA isolated from macrophages and 10 3 -10 5 molecules of pAW 109 cRNA per reaction and incubated for 10 min at room temperature followed by 15 min at 42ЊC, 5 min at 99ЊC, and cooled at 5ЊC for 5 min. The oligonucleotide primer pairs for TNF-␣ and IL-1␤ mRNA suggested by Wang (50) were used. The amplification profile for TNF-␣ cDNA involved heating to 95ЊC for 2 min, denaturation at 95ЊC for 1 min, and annealing-extension at 64ЊC for 31 cycles in Biometra Tri-Thermoblock (Biometra, Göttingen, Germany). The amplification profile for IL-1␤ cDNA was performed under the same conditions as TNF-␣, except that the annealingextension reaction was performed at 65ЊC for 32 cycles. The PCR products were separated on 4% NuSieve GTG agarose gel (FMC Bioproducts, Rockland, ME) for 2-5 h. The gel was stained with ethidium bromide (Merck, Darmstadt, Germany), and appropriate bands were excised, and radioactivity was determined by liquid scintillation counting. In the exponential phase of the amplification the amount of target mRNA was quantitated against the internal standard curve. The LPS-induced TNF-␣ and IL-1␤ mRNA expression was set to 100%.
Expression of TNF-␣ and IL-1␤ in macrophages. Synthesis of TNF-␣ and IL-1␤ was evaluated with an immunoassay using ELISA kits from Immunotech, Marseille, France. Expression of TNF-␣ was followed in the medium, while expression of IL-1␤ was followed in the cytosol. 3 h of LPS-exposure to the macrophages was allowed before monitoring the expression of TNF-␣ and IL-1␤. The samples were assayed in duplicates. The LPS-induced TNF-␣ and IL-1␤ protein expression was set to 100%.
Cell viability. Macrophage growth in culture was determined using the cell proliferation kit II (XTT; Boehringer Mannheim) according to the manufacturer's instructions.
Results
OxLDL inhibits LPS-induced binding of NF-B and the constitutive binding of AP-1 and SRF ϩ SAP-1 to DNA. LDL from two donors was pooled and oxidized for 2.5, 4, and 13 h. These three variants of oxidized LDL were incubated with macrophages from three donors. This experiment was repeated five times to study the variations in the experimental results in relation to the variability in LDL with macrophages obtained from different donors.
Proteins in nuclear extracts from human macrophages treated for 24 h with oxLDL, 50 g/ml, followed by LPS, 1 g/ ml, for 1 h were analyzed by EMSA for binding to an ␣ 32 Plabeled oligonucleotide from the c-fos promotor containing both the serum responsive element and the AP-1-binding site and an ␣ 32 P-labeled oligonucleotide containing a NF-B-bind- Figure 7 . Effect of oxLDL and LPS on the DNA-binding of Oct-1. NE from human monocyte-derived macrophages treated with oxLDL were analyzed for protein binding to the octamer consensus sequence by electrophoretic mobility shift assay. An equal protein amount of NE was added to each binding reaction. NE from untreated macrophages (C), macrophages treated with oxLDL, 50 g/ml, for 24 h (O), treated with LPS, 1 g/ml, for 1 h (L), and macrophages treated with oxLDL, 50 g/ml for 24 h before exposure of LPS, 1 g/ml, for 1 h (P); only oligonucleotide (N). Unbound oligonucleotide is at the bottom.
ing motif from the TNF-␣ promotor. The DNA-binding of the transcription factors NF-B, AP-1, and SRF ϩ SAP-1 found after EMSA, from macrophages exposed to LPS only was set to 100% (see Methods).
A typical effect of oxLDL on the LPS-induced binding of NF-B, AP-1, and SRF ϩ SAP-1 after EMSA is shown in Fig.  2 . The results obtained after laser densitometry scanning of the autoradiographs from EMSA from five experiments with monocyte-derived macrophages and LDL from several donors are summarized in Figs. 3, 4 , and 5.
The results in Figs. 2 and 3 show that almost no binding to the B site was found in nuclear protein extracts from untreated macrophages, since NF-B is a LPS-inducible transcription factor. Similar results was found with nuclear protein extract from macrophages incubated with oxLDL, demon-strating that oxLDL did not in itself induce binding of NF-B to the TNF-␣ promotor (Figs. 2 and 3. ). Treatment of macrophages with LPS, 1 g/ml, for 1 h induced binding of NF-B to the TNF-␣ promotor, which was set to 100% (Fig. 3) . The response of NF-B to LPS was reduced to 67%, when macrophages were pre-treated with medium oxidized LDL for 24 h (Fig. 3 ). Highly oxidized LDL even further reduced the LPSinduced binding of NF-B to the TNF-␣ promotor to 20% (Fig. 3 ). However, low oxLDL, in contrast to highly oxLDL, had only a small impact on the inhibition of the LPS-induced response on NF-B (Fig. 3) . Apparently, the inhibiting effect of oxLDL on the LPS-induced binding of NF-B to the TNF-␣ promotor was related to the degree of the oxidation of LDL.
AP-1 was, in contrast to NF-B, constitutively bound to the oligonucleotide used for EMSA ( Figs. 2 and 4 ). Medium and Figure 8 . Effects of oxysterols on the DNA-binding of AP-1, SRF ϩ SAP-1 and NF-B. NE from human monocyte-derived macrophages analyzed by electrophoretic mobility shift assay for binding to the same ␣ 32 P-labeled oligonucleotides as in Fig. 2 . An equal protein amount of NE was added to each binding reaction. NE from untreated macrophages (C) and macrophages treated with oxysterols, 5 g/ml, for 24 h (S) and with LPS, 1 g/ml, for 1 h (L), and macrophages treated with oxysterols for 24 h before exposure of LPS, 1 g/ml for 1 h (P). The individual oxysterols used are indicated on top. The identified transcription factors SRF ϩ SAP-1, AP-1, and NF-B are indicated. highly oxidized LDL, decreased the constitutive binding of AP-1 to the c-fos promotor to 68 and 56% respectively ( Fig.  4) , while no effect was found with LPS.
The SRF ϩ SAP-1 complex, like AP-1, was found to be constitutively bound to SRE (Fig. 5 ). The binding of SRF ϩ SAP-1 to SRE after LPS exposure was set to 100%. Medium and highly oxidized LDL decreased the constitutively bound SRF ϩ SAP-1 complex to 78 and 66%, respectively (Fig. 5) . This pattern was similar to that obtained with AP-1.
To study whether the inhibiting effects on the binding of NF-B and AP-1 to DNA were reversible, the following experiment was performed: Macrophages were exposed to highly oxidized LDL for 24 h under the same conditions as previously described. Only 9% of the LPS-induced DNA-binding of NF-B was found in macrophages incubated with highly oxLDL (Fig. 6 ), which is in agreement with our other previous results shown in Fig. 2 . For the AP-1-binding only 36% of the LPSinduced binding was found. After 24 h treatment with highly oxLDL, the medium was replaced with the same medium for another 2 d but without oxidized LDL. When the macrophages after these 2 d were exposed to LPS, 1 g/ml, a 70% response of the NF-B-binding to DNA was found, in comparison to cells treated only with LPS. No difference was found for the AP-1-binding, in comparison to macrophages exposed to LPS only, since 104% binding was found in macrophages that previously had been exposed to highly oxLDL. The binding to the octamer motif did not change during these experiments (Fig. 6) .
These results taken together demonstrate that the inhibiting effects on the binding of AP-1 and NF-B to DNA in macrophages treated with highly oxLDL before LPS-exposure were reversible and probably due to specific effects of oxidized LDL on these transcription factors, since no differences in binding to the octamer motif on DNA were found ( Figs. 6 and 7) .
Effects of oxysterols on the binding of AP-1 and NF-B to DNA. We examined a number of oxysterols, indicated in Fig.  8 , to investigate whether they could mediate the effects found with oxidized LDL on the binding of AP-1, SRF ϩ SAP-1, and NF-B to DNA. Macrophages were incubated with increasing concentrations of 7␤-hydroxycholesterol to investigate at which level the maximal inhibition of the constitutive binding of AP-1 to DNA was found. The results illustrated in Fig. 9 show a dose-dependent effect of 7␤-hydroxycholesterol on the binding of AP-1 to DNA up to 5.0 g/ml. The concentration of the oxysterols used was therefore chosen to 5.0 g/ml. The macrophages were incubated with oxysterols, 5 g/ml, for 24 h, before LPS-exposure for 1 h. Macrophages were incubated with cholesterol, 5 g/ml, as control to the oxysterols.
The results obtained after EMSA showed that no binding of NF-B to DNA was found in the cells treated with cholesterol and oxysterols ( Fig. 8 ). LPS induced binding of NF-B to DNA in untreated macrophages as well as in cells pretreated with oxysterols. These results demonstrate that oxysterols in oxLDL are not able to inhibit the LPS-induced binding of NF-B, found in human macrophages incubated with highly oxidized LDL. Similar results were observed in two separate experiments.
A decreased DNA-binding of AP-1 to ‫ف‬ 50-70% was found in macrophages incubated with 7␤-hydroxycholesterol, 24-hydroxycholesterol, 27-hydroxycholesterol, and 25-hydroxycholesterol, while no effect was found with LPS. These results indicate an inhibiting effect on the constitutive DNA-binding of AP-1 by oxysterols. Similar results were observed in two separate experiments.
Identification of the transcription factors NF-B, AP-1, and SRF ϩ SAP-1. A specific antibody to the p65 subunit of NF-B was used to identify the electrophoretical band corresponding to NF-B after EMSA with the oligonucleotide from the TNF-␣ promotor containing a NF-B-binding site. Only the electrophoretic band induced after LPS was supershifted with the specific antibody against NF-B (results not shown).
To further demonstrate that the retarded band, obtained after EMSA, was NF-B, a competition experiment was performed. A specific competitor including a B motif from the human TNF-␣ promotor from Ϫ223 to Ϫ190 was added in molar excess. A nonspecific competitor was also added, which did not have any binding sites for NF-B, and therefore did not compete with the specific oligonucleotide. The specific oligonucleotide containing the B motif competed with the band earlier identified as NF-B (results not shown). Thus the competition experiment confirmed the results obtained with the specific antibody. The B motif in the oligonucleotide used as a competitor had an apparently lower affinity for NF-B than the B motif in the labeled oligonucleotide, since 200 molar excess of competitor was needed to abolish binding.
The transcription factor SRF is known to bind to SRE either by itself or in a complex with SAP-1 (25) (26) (27) (28) . SAP-1 is, in contrast to SRF, not able to bind to SRE by itself (27) . Therefore, SRF is a prerequisite for binding of SAP-1 to DNA. To identify the SRF ϩ SAP-1 complex bound to SRE, a specific antibody against SAP-1 was added to the protein-DNA-binding reaction. A supershifted band was found after EMSA with the antibody against SAP-1, demonstrating the SRF ϩ SAP-1 complex (Fig. 10) .
To identify the AP-1-binding site flanking the serum responsive element on the c-fos promotor, shown in Fig. 1, a competition experiment was performed, using the consensus sequence of the AP-1-binding site (46) (Fig. 1) . When molar excess of the oligonucleotide containing the AP-1-binding consensus sequence was added to the binding reaction, a specific protein-DNA-binding complex was competed with the c-fos promotor (Fig. 10 B) . 400 molar excess of the NF-B-binding sequence did not affect any of the protein-DNA complex on the oligonucleotide from the c-fos promotor, demonstrating that the competetion with the AP-1-binding site was specific ( Fig. 10 B) . To further verify the electrophoretical localization of the AP-1-DNA complexes, recombinant c-jun, forming a homodimer of the AP-1 complex, was allowed to bind to the oligonucleotide from the c-fos promotor. The c-jun homodimer form of the AP-1 complex was shown to have similar electrophoretical mobility as the protein-DNA complex, which was competed with the oligonucleotide containing the consensus sequence for AP-1 ( Fig. 10 B) (46) .
The oligonucleotide containing the consensus sequence of the AP-1-binding site was used to study the binding of AP-1 from macrophage nuclear protein extracts in detail. With this oligonucleotide only one retarded band was found with the nuclear protein extract from macrophages treated with low oxidized LDL (Fig. 10 C) . This electrophoretic band had a similar mobility as the band obtained, when recombinant c-jun formed a homodimer of AP-1 and was bound to the same AP-1 oligonucleotide (Fig. 10 C) . A specific antibody against c-fos in the AP-1 complex was also used to identify the electro-phoretical, shifted band obtained with the nuclear protein extract. A supershifted band was observed when nuclear protein extract from macrophages treated with low oxidized LDL was analyzed with this antibody (Fig. 10 C) . In conclusion, these results demonstrate that AP-1 in macrophage nuclear protein extract was bound to the AP-1 probe.
Highly oxidized LDL decreased the LPS-induced TNF-␣ and IL-1␤ mRNA expression. LPS-induced gene expression of TNF-␣ and IL-1␤ is mediated by DNA-binding of NF-B to the TNF-␣ and IL-1␤ promotors (13) . Total RNA from macrophages was isolated to investigate the effect of oxLDL on the LPS-induced TNF-␣ and IL-␤ mRNA expression. Results from three experiments are summarized in Fig. 11 . These results showed that LPS-induced IL-1␤ and TNF-␣ mRNA expression was reduced to 10 and 26%, respectively, in macrophages incubated with highly oxLDL before LPS-exposure. Highly oxidized LDL in itself did not induce mRNA expression of TNF-␣ and IL-1␤. These results are in agreement with the DNA-binding of NF-B and AP-1 in nuclear protein extracts from macrophages incubated with highly oxLDL before LPS-exposure.
Oxidized LDL inhibits LPS-induced TNF-␣ and IL-1␤ protein synthesis. The TNF-␣ and IL-1␤ protein synthesis were followed to further study the consequences of the decreased LPS-induced binding of NF-B and AP-1 to the TNF-␣ and IL-1␤ promotors. The results obtained for the TNF-␣ protein expression from three experiments, illustrated in Fig. 12 , demonstrate that low oxLDL decreased the LPS-induced synthesis of TNF-␣ to 26%, while medium and highly oxidized LDL decreased the LPS-induced synthesis to 11 and 1%, respectively. The results for the LPS-induced IL-1␤ protein synthesis are shown in Fig. 13 . Low oxLDL decreased the LPSinduced expression of IL-1␤ to 93%, while medium oxLDL decreased this expression to 48% and highly oxLDL decreased Figure 11 . Effect of highly oxidized LDL on the LPS-induced IL-1␤ and TNF-␣ mRNA expression in human macrophages. Total cellular RNA was extracted for quantitative RT-PCR analyses of IL-1␤ and TNF-␣ mRNA as described under Methods. Expression in untreated (C) macrophages; in macrophages treated with oxLDL, 50 g/ml for 24 h (O); in macrophages exposed to LPS, 1 g/ml, for 3 h (L) (set to 100%) and mRNA expression in macrophages treated with oxLDL, 50 g/ml for 24 h before exposure of LPS, 1 g/ml, for 3 h (P). The results are represented as mean values from three experiments, and SEM is indicated. Figure 12 . Effect of oxidized LDL on the LPS-induced TNF-␣ protein secretion. The TNF-␣ protein secretion was measured in cell culture medium, by ELISA, from untreated macrophages (C); macrophages treated with oxLDL, 50 g/ml for 24 h (O); macrophages exposed to LPS, 1 g/ml, for 3 h (L) (set to 100%) and TNF-␣ secretion from macrophages after treatment with oxLDL 50 g/ml for 24 h before exposure of LPS, 1 g/ml, for 3 h (P). The results are represented as mean values from three experiments, and SEM is indicated. Figure 13 . Effect of oxidized LDL on the LPS-induced IL-1␤ protein expression. The intracellular IL-1␤ protein expression, measured by ELISA, in untreated macrophages (C); in macrophages treated with oxLDL, 50 g/ml for 24 h (O); in macrophages exposed to LPS, 1 g/ ml, for 3 h (L) (set to 100%) and the IL-1␤ protein expression in macrophages treated with oxLDL, 50 g/ml, for 24 h before exposure of LPS, 1 g/ml, for 3 h (P). The results are represented as mean values from three experiments, and SEM is indicated.
the LPS-induced IL-1␤ expression to 28%. No TNF-␣ and IL-1␤ protein expression were found in untreated macrophages or in macrophages incubated with oxLDL. These results are therefore in line with those results obtained for the TNF-␣ and IL-1␤ mRNA expression.
Discussion
In this study we have demonstrated that the LPS-induced binding of NF-B to the TNF-␣ promotor in human monocyte-derived macrophages exposed to oxidized LDL decreases. We have also shown that oxLDL, in itself, does not affect the DNA-binding of NF-B. The effect of the decreased LPSinduced DNA-binding of NF-B was also investigated at the level of mRNA and protein expression of TNF-␣ and IL-1␤. After LPS-exposure both TNF-␣ and IL-1␤ mRNA and protein expression were found. However, no TNF-␣ or IL-1␤ expression were found in untreated macrophages or in macrophages incubated with oxLDL. These observations are in agreement with previous results, which also include other genes (11, 12, 52) . When, after exposure to oxLDL, the LPSinduced binding of NF-B to the TNF-␣ promotor dropped to 20% the corresponding mRNA expression was reduced to 26%. These results demonstrate a correlation between the binding of NF-B to its binding sites on the human TNF-␣ promotor and the subsequent TNF-␣ mRNA expression. Also the LPS-induced IL-␤ mRNA expression was reduced after exposure of the cells to highly oxidized LDL. In oxLDL-treated cells the LPS-induced mRNA for IL-1␤, after 3 h, was only 10% of the level in cells exposed to only LPS. The LPSinduced IL-1␤ mRNA expression is known to have its peak after 2-4 h (53). When macrophages were treated with oxLDL before LPS-exposure, a decrease in TNF-␣ and IL-1␤ protein expression was also observed. The simultaneous decrease of the binding of NF-B to DNA, the mRNA, and protein expression indicate that oxLDL inhibits the transcriptional activity of the TNF-␣ and IL-1␤ genes. It has been shown by others (52) that the LPS-induced TNF-␣ mRNA expression is due to the transcriptional activity of the TNF-␣ gene, while no transcriptional activity was found in control cells or cells exposed to oxLDL (52) . Although a decreased transcriptional activity probably explains the decreased response to LPS after exposure to oxLDL, we cannot exclude the possibility that oxLDL may also affect the translation and the posttranslational regulation of the TNF-␣ and IL-1␤ expression. Little is known concerning the stability of TNF-␣ mRNA in primary macrophage cultures and possible variation in mRNA stability in parallel with changes in translation efficiency (54) .
In this study we have also shown that highly oxLDL inhibited the constitutive binding of AP-1 and SRF ϩ SAP-1 to their binding sites to 56 and 66%, respectively. The low LPSinduced IL-1␤ mRNA expression in these cells could therefore be due to the decreased binding of these two transcription factor complexes, since the IL-1␤ promotor contains two AP-1binding sites and one serum responsive element (16) .
The drop in the SRF ϩ SAP-1-binding to SRE was followed by a similar decrease in the AP-1-binding to the c-fos promotor in macrophages incubated with oxLDL. The c-fos protein is a constituent of the AP-1 complex, as shown with the specific antibody against c-fos in Fig. 10 C. These results might therefore indicate that oxLDL inhibits the c-fos gene expression, by decreasing the constitutive binding of the SRF ϩ SAP-1 complex to SRE on the c-fos promotor, since the binding of this complex to SRE is necessary for transcription of the c-fos gene (26) (27) (28) . In addition, both c-fos, c-jun and SRF ϩ SAP-1 need to be phosphorylated to induce transcription (23, 24, 26) .
A common factor for the described effects of oxLDL on NF-B, AP-1, and SRF ϩ SAP-1 is that these transcription factors are dependent on phosphorylation for their activation (17-19, 23, 24, 28) . In contrast, the transcription factor Oct-1, which is not induced by phosporylation, was unaffected by oxLDL ( Figs. 6 and 7) (48) .
Which factor in oxLDL is responsible for the observed effects on macrophages is unknown. Lipid uptake into macrophages via scavenger receptors can also be generated by AcLDL (55). AcLDL, however, has no effect on the LPSinduced secretion of IL-1␤ (11) . Among the constituents of oxLDL, lipid oxidation products have been suggested to have important biological effects (37) (38) (39) . One group of such products are the oxysterols, generated by oxidation of cholesterol (56, 57) . Oxysterols are biologically active molecules which, for example, inhibit the LDL receptor function in human fibroblasts (33), reduce the LPL mRNA expression in human macrophage cells (51) , and decrease the synthesis of PGI 2 in endothelial cells (58) . In addition, oxysterols have also been found to be cytotoxic to endothelial cells and smooth muscle cells in vitro (59) (60) (61) (62) . Furthermore, oxysterols have been identified in tissue from atherosclerotic human aortas (34) (35) (36) (37) (38) (39) . To investigate if the observed effects of oxLDL were mediated through oxysterols we investigated a series of different oxysterols and their effect on the transcription factors NF-B and AP-1. In this study we found a decreased constitutive DNAbinding of AP-1 to ‫ف‬ 50-70% in macrophages incubated with 7␤-hydroxy, 24-hydroxy, 25-hydroxy, and 27-hydroxy-cholesterol, while almost no effects of the oxysterols were found on the LPS-induced DNA-binding of NF-B. Apparently, constituents other than the oxysterols studied are responsible for the inhibition of LPS-induced activation of NF-B. Several such components have been suggested, such as various aldehydes (63) , lysophosphatidylcholine (64, 65), or other degradation products of phospholipids (6) . As shown by others, the components in oxLDL that conduct the inhibiting effect of the LPSinduced expression of IL-1␤ in macrophages are bound to the LDL particle (11, 52) .
In the present study we have used human monocytes allowed to differentiate in a serum-free medium in the presence of GM-CSF. This system was found to give very reproducible results, even with cells from different donors. The variability involved in using different batches of human serum was hereby avoided, and in using a serum-free medium the risk of contamination with endotoxin could be minimized.
Similar results to those obtained by us have been found in studies on macrophages incubated with glucocorticoids (66, 67) . Glucocorticoids were found to reduce LPS-induced binding of NF-B as well as the constitutive binding of AP-1 to DNA, while binding of the transcription factor Oct-1 to DNA was unaffected. These authors found that dexamethasone induced the expression of IB in the cytoplasm (66, 67) . When macrophages were exposed to LPS, the NF-B-IB complex dissociated after IB was phosphorylated, but NF-B was then bound to another unphosphorylated IB. The excess of IB in comparison to NF-B inhibited the translocation of NF-B from the cytoplasm to the nucleus. In our experiment only 20% of the LPS-activated NF-B was found in the nuclear protein extract from macrophages exposed to highly oxidized LDL. Our results might suggest that oxLDL may inhibit the translocation of NF-B from the cytoplasm to the nucleus and the subsequently transcriptional expression of the TNF-␣ gene.
The most extensive studies have been performed regarding the effects of MM-LDL on the induced inflammatory responses in endothelial cells as well as on the induced monocyte and endothelial interactions (5, 6) . These studies suggest that MM-LDL activates the endothelial cells in several respects and that MM-LDL actually induces a binding of NF-B to DNA (5) . In human vascular smooth muscle cells MM-oxLDL had no effect on the DNA-binding activity of NF-B, while highly oxLDL inhibited a LPS-induced DNA-binding of NF-B (68) . In contrast to our results both MM-oxLDL and highly oxLDL induced DNA-binding of AP-1 (68) . MM-oxLDL and more extensively oxidized LDL have different constituents (29, 64) . The biological effects of MM-oxLDL and oxLDL are, therefore, probably very different. In addition, various cell types in culture apparently react differently on MM-oxLDL and on highly oxLDL.
In the atherosclerotic lesion, LDL is supposed to be bound to the extracellular matrix and then modified by oxidation (45, 69) . Oxidized LDL is then taken up by macrophages leading to an accumulation within the foam cells of cholesterol as well as lipid oxidation products, such as oxysterol (32) . The results from this study might indicate that oxidized LDL could inhibit or minimize a normal inflammatory response. It has been speculated that the suppression of cytokine expression in foam cells may be an important contributing factor of the pathophysiologic process in the formation of fatty streaks before they convert to mature atheromas (52) . The capacity of macrophages in lesions to be activated might also be crucial for the stability of the atherosclerotic plaque as well as for the thrombosis formation on the plaque surface. To further elucidate macrophage function in atherosclerosis, therefore, is essential for the understanding of plaque formation as well as for the development of complicated lesions with plaque rupture and thrombosis formation.
